Background. Development and humanitarian aid workers are a diverse group of travelers who, because of the nature of their travel, may have specific travel-related health risks. The main objective of this study was to quantify the risk of dengue fever virus (DFV), tuberculosis (TB), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) infections in a group of long-term development aid volunteers. Methods. Medical files of Volunteer Service Abroad (VSA) volunteers and their accompanying family/partner/spouse serving over 17 years (1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011) were reviewed. Demographics, destination, months spent in-country, and, where available, results of preand post-assignment testing for DFV, TB, HCV and HIV infections were extracted. Results. Results from 652 assignments were audited. Conversion rates were calculated when both pre-and post-assignment results were available. Evidence of dengue fever seroconversion was found in 6.3% of 205 volunteers [at a rate of 3.4 per 1,000 person months (pm) on assignment], with assignments in Southeast Asia having the highest risk. Evidence of TB during assignment was found in 2.9% of 336 volunteers converting at a rate of 1.4 per 1,000 pm. There were no HIV or HCV infections detected. On post-assignment questioning, 6.7% of volunteers reported unprotected sex with someone other than their regular partner and 9.8% reported a potential exposure to blood and/or blood products. Conclusions. Infection with DFV and TB occurred in this group at rates similar to that seen in other groups of long-term travelers, and screening would appear to be warranted. While none contracted HIV or HCV infection, reported behavior did put them at risk of blood-and body fluid-borne diseases. It is important that pre-assignment travel health preparation in this group focuses on strategies to minimize these risks.
D evelopment and humanitarian aid workers are a diverse group of travelers at risk of travel-related health issues. Their travel is often prolonged; they work in close contact with local populations in predominantly tropical, resource-poor, and remote settings. While there is evidence that aid workers have better knowledge of travel-related health risks, 1 significant risk-taking behavior has been recorded in this group. [2] [3] [4] Volunteer Service Abroad (VSA) is a New Zealand (NZ)-based development aid organization that has placed more than 3,500 skilled volunteers on assignment to developing countries throughout Melanesia, Polynesia, Asia, and Africa since 1962. 5 Assignment length varies, but most are of 2 years' Corresponding Author: Jenny T. Visser, MbCHB, University of Otago, Wellington, New Zealand. E-mail: jenny.visser@otago.ac.nz duration. Volunteers are often accompanied by a spouse or partner and occasionally children.
As a sponsoring organization, VSA has accepted a duty of care to minimize health risks associated with assignments. Volunteers partake in a comprehensive medical program including pre-and post-assignment screening for a number of infectious diseases. The diseases screened for have grown over the years and currently they include dengue fever, tuberculosis (TB), acquired immunodeficiency syndrome (AIDS), and hepatitis C. Patients were screened for these specific diseases for a number of reasons including that they are at recognized risk for these diseases, which lend themselves to pre-and post-assignment testing. All have potential impact on the health of the volunteers and, most importantly, knowledge of status allows for interventions both during and after assignment, which can lessen the personal and public health threat. For example, evidence of TB exposure would prompt further investigation for disease, consideration for isonizid therapy for presumed latent TB, and/or careful monitoring for early symptoms of active TB. For some infections other strategies are employed. Preassignment hepatitis B vaccination is mandatory for nonimmune volunteers. Some (mainly owing to cost constraints) are targeted for screening. This may be toward those with higher risk exposures, unresolved symptoms, or prompted by other laboratory findings. For example, an unexplained eosinophilia might prompt screening for schistosomiasis and/or strongyloidiasis.
Methods
Ethics approval was granted internally by the University of Otago. Medical files of VSA volunteers serving over 17 years (1995-2011) and their accompanying family/partner/spouse were audited. Demographics, destination, months spent in-country, and results of routine pre-and post-assignment testing for dengue fever, TB, hepatitis C, and HIV infections were extracted.
Testing for DFV, HIV, and HCV infections was done by virus-specific antibody testing. For DFV Pan Bio ® kits (Inverness Medical Innovations Australia Pty Ltd, Queensland, Australia) were used (''Dengue IgM Capture ELISA'': 95% sensitivity and 100% specificity and ''Dengue IgG Indirect ELISA'': 98% sensitivity and 100% specificity). 6 Baseline TB status was determined by two methods: prior to 2007 tuberculin skin testing (TST) (two-step Mantoux) was used; in 2007 this was replaced by a tuberculin interferon gamma release assay, QuantiFERON ® TB Gold (QFG) (Cellestis, Qiagen Pty Ltd, Chadstone, Victoria, Australia).
Dengue fever seroconversion was defined as an observed pre-assignment negative to post-assignment positive dengue fever immunoglobulin G (IgG). A TB conversion was defined as either a Mantoux increase of 10 mm or more, or a change from negative to positive QFG assay.
Prevalence was calculated using OpenEpi software. Conversion rates were calculated as per 1,000 person months (pm). Confidence intervals for these estimates were calculated as follows. For proportions, Fisher's exact confidence interval was used; confidence intervals for rates were calculated using the Delta method.
Data on the number of volunteers reporting unprotected sexual contact with someone other than their regular partner and those who had potential exposure to blood/blood products were extracted from direct questions embedded in the post-assignment medicals.
Results
The files of 607 volunteers and their accompanying partner/spouse and family members undertaking a total of 652 assignments were audited (some had been on more than one assignment during the study period). Over half (55%) were female. While all age groups were represented, the median age was 50 years ( Table 1) . The median assignment length was 22 months (range, 2-73 months). Assignments were done in 19 countries, across six regions. Destinations within Melanesia accounted for 38% of all volunteer placements with the Autonomous Region of Bougainville being the most common country (Table 2) .
While 652 assignments were audited, the number of assignments where both pre-and post-assignment results were available is less than this figure and varied for the four infections. Where pre-assignment screening for either TB or dengue fever was positive, post-assignment screening was not done as repeat testing would not be able to differentiate between distant or recent infection. Over the 17-year timeframe, policy changed regarding which diseases were included (dengue fever being the most recently included). Not all completed a post-assignment medical. The number refusing post-assignment medicals has not been recorded, but anecdotally it is few. More commonly, returning volunteers failed to complete all postassignment testing, for example, not returning for the TST read.
Pre-assignment evidence of DFV infection was found in 11.1%. Only 6.3% of 205 volunteers seroconverted during the assignment [at a rate of 3.4 per 1,000 pm on assignment (Table 3) ]. Volunteers to Southeast Asia had statistically significant higher prevalence and conversion rates of DFV infection compared with other regions (Table 4) .
Positive baseline TB testing (all latent TB as none had evidence of TB disease) was found in 11.9%. In all, 2.9% of 336 volunteers had evidence of TB infection during assignment converting at a rate of 1.4 per 1,000 pm (Table 3) . Rates were not statistically significantly different between geographical regions (Table 5 ).
There were no HIV or HCV infections detected either pre-assignment or post-assignment. On postassignment questioning, 6.7% [95% confidence interval (CI) 4.6-9.4] of volunteers reported unprotected sex with someone other than their regular partner. A total of 9.8% (95% CI 7.3-12.3) reported a potential exposure to blood and/or blood products. Exposures included medical interventions in-country [injections/blood tests/intravenous drips (56.7%), immunizations (13.3%), and blood donation (6.7%)], nonmedical interventions [tattoos/piercings (10%) and acupuncture (6.7%)], exposure to blood during a motor vehicle accident response (3.3%), and occupational exposure [midwifery practice (3.3%)].
Discussion
While there is considerable variation in the reported prevalence of dengue in travelers, the post-assignment prevalence in this study was similar to that observed in studies of long-term travelers [7] [8] [9] [10] [11] [12] [13] [14] (Figure 1 ). While not the sole determinant of dengue risk, DFV infection appears to increase with time spent in endemic areas (Figure 1 ). Specifically in aid workers, those on shortterm assignments 15, 16 reported lower rates than those on longer assignments. 7, 9 Humanitarian and development aid assignments are often for prolonged periods of time, with a mean assignment time of 22 months, and time spent in endemic areas will be the one risk factor for DFV infection in the group studied here. DFV infection in travelers will also reflect local epidemiology; compared to an audit of another group of NZ travelers (members of NZ Police who have been deployed overseas 13 ) the prevalence of DFV infection per trip in both groups was similar, but the conversion rates per 1,000 pm spent in-country were significantly higher in NZ Police (Figure 2 ), largely reflecting NZ Police deployments to East Timor during a time of heightened dengue. 13 In this audit, volunteers returning from the Southeast Asia region had the highest prevalence and rates of DFV conversions (Table 4) . Southeast Asia has been shown to be a region with higher risk of DFV acquisition for travelers 13, 17, 18 as have the Pacific Island nations. 19 While dengue fever 
Figure 1 Reported percentage of dengue fever virus (DFV) conversions (with 95% confidence intervals).
outbreaks occur in Africa, they are comparatively rare. 20 With NZ government funding targeting aid projects within the Southeast Asian and Pacific regions, 21 it is likely that NZ-based aid workers will continue to be at risk of contracting dengue fever.
Published studies to date have not been able to determine if humanitarian aid workers, by virtue of the nature of their work alone, are at increased risk of DFV infection compared with other travelers.
This audit found baseline positive dengue serology in 11.1%. One risk factor for severe dengue is thought to be previous infection with a different serotype 22 ; given all VSA assignments are to dengue-endemic countries, this places them at increased risk of severe dengue (although none were observed in this cohort among those with evidence of prior infection). This baseline positive dengue was higher than that found in Dutch travelers (6.5%) 23 and in NZ Police deployed overseas (1.98%). 13 New Zealand is not endemic for any human flavivirus; therefore, this baseline most likely represents infection due to prior travel or residence in endemic countries or previous flavivirus vaccine cross reactivity. 24 Cross reactivity with flavivirus vaccinations could overestimate positive dengue serology both preassignment and post-assignment. VSA volunteers tend to be experienced travelers and a large number had spent significant time overseas on other humanitarian aid projects. Some are likely to have received vaccination against either Japanese encephalitis or yellow fever prior to baseline testing. Almost half of all volunteers in this audit went on assignment to countries where preassignment vaccination for either Japanese encephalitis (33.3%) or yellow fever (9.5%) was required by the organization; again, this could have contributed to an overestimation of dengue seroconversions (vaccinations are commenced after baseline blood samples are taken).
This audit could also underestimate DFV infection; not all volunteers completed post-assignment medicals (this could also introduce bias, those who chose to not complete medicals may have differed in infection risk to those who did). Those who reported a diagnosis of dengue in-country often opted for no further testing on return (and often had no record of in-country testing results).
The observed 2.9% (95% CI 1.4-5.4) of VSA volunteers converting for TB is similar to that reported in a number of studies of travelers. [25] [26] [27] It also compares favorably with the 2% (99% CI 1.6-2.4) incidence for travelers calculated in a recent meta-analysis. 28 Compared with another group of aid workers, a study of TB conversions in Peace Corps volunteers 26 reported very similar prevalence and conversion rates (2.3% converting at a rate of 1.3/1,000 pm). Compared with NZ Police (who deploy to similar destinations but for shorter periods of time), VSA volunteers appeared to have both higher conversion prevalence and conversion rates (although these were not statistically significant). 13 All volunteers with evidence of TB conversion were further investigated for active TB including chest X-ray. None were found to have evidence of active TB (although one volunteer was diagnosed with pulmonary TB while on assignment in South Africa). They were also referred for further discussion of treatment of presumed latent TB.
The baseline level of latent TB (11.9%) found in this audit was interesting. Accurate data on the prevalence of latent TB in the NZ population is lacking, 29 so it is not known if this is typical of the wider NZ population. However, it is very similar to the 10.38% latent TB found on pre-deployment screening in NZ Police. 13 With regard to dengue fever, prior travel to or residence in high TB prevalence countries may account for this observation.
Both TST and QFG testing for TB can produce false-positive and false-negative results. Previous Bacillus Calmette-Guerin (BCG) vaccination, exposure to non-human mycobacteria, the boosting effect of serial tests, and subjectivity of readings may cause an overestimation of positive TSTs. The gamma interferon release assays appear to overcome some of these limitations; however, there remains some uncertainty around their sensitivity, specificity, and positive predictive value, especially in populations with low endemicity. 30, 31 Just over one quarter (26.5%) of volunteers in this audit had received BCG vaccination as children or young adults, which may have offered them some protection against TB infection.
Data on HCV infections in travelers is scarce 32 and studies have generally recorded low levels of HIV and HCV infections in travelers, [33] [34] [35] [36] so it is not surprising that neither positive baselines nor seroconversions for either HIV or HCV were recorded in this group. The 9.8% of volunteers reporting potential blood exposure (especially those opting to have tattoos and body piercings while on assignment) and the 6.7% reporting unprotected sexual contacts demonstrates, however, that these diseases remain potential risks.
It is known that travelers are at risk of sexually transmitted infections (STIs) including HIV. 37 In a study of British Volunteer Service Overseas (VSO) volunteers, 3 11.0% of volunteers had placed themselves at risk of HIV and STIs This is higher than the 6.7% reported in this audit. Results for both VSO and VSA are lower than other studies 36, 38, 39 possibly because older studies are reflecting behavior in the pre-and early HIV/AIDS era. A recent systematic review and meta-analysis of STI risk-taking behavior during foreign travel gave a pooled prevalence of travelassociated casual sex of 20.4%, with 49.4% of these having unprotected intercourse. 37 This same review noted that those who traveled or stayed abroad for longer periods were more likely to develop new sexual partnerships and to have unprotected intercourse, both risk factors for long duration aid workers such as VSA volunteers.
Bhatta and colleagues 3 suggested that lower levels of HIV/STI risk-taking behavior among British VSO volunteers may have been due to pre-trip health advice. One small study of expatriates in Ghana found that those who received pre-travel advice were more likely to use condoms 39 ; however, others 40, 41 have failed to show that pre-travel counseling reduced STI risk-taking behavior. VSA volunteers are given both individual and group pre-assignment medical advice including safer sex messages and all are provided with condoms in their medical kits. Younger age and traveling solo have also been identified as risk factors for unsafe sex while traveling. 37 VSA volunteers are often accompanied by their partners/spouses and their median age is 50 years, and these factors may contribute to the lower levels of risk behavior reported.
Females may be more likely to have riskier sex while traveling. 4 In our audit, 70% of those reporting unsafe sex were female (while females made up 55% of volunteers); however, this could be due to females being more likely to admit to unsafe sex than males. The data gathered from this question should be interpreted with caution as it is likely to be subject to recall bias and underreporting.
Conclusion
Volunteers experience a range of health problems during and after their assignments in the developing world. For some infections, the impact may be reduced by pre-and post-assignment screening. The prevalence of latent TB and prior DFV exposure found on pre-assignment screening suggests that screening is worthwhile. Post-assignment screening detected over 6% DFV and almost 3% TB exposure while on assignment. While the impact of DFV is most likely of greatest significance while on assignment, infection with TB can have long-term health implications, which can be reduced by treatment of TB disease and latent TB.
The zero rates of both baseline and returning HIV and HCV suggest that routine screening for these could be replaced by targeted screening, especially given the percentages of returning volunteers who reported risky activities.
While little may be able to be done to prevent exposure to TB in volunteers who are living for extended periods of time in high prevalence countries, the findings of this study reinforce the need for on-going pre-assignment education on the prevention of vectorborne diseases, the importance of safer sex behavior, and avoidance of blood-borne diseases.
